Sanofi India formerly known as Aventis Pharma has recently launched Combiflam Plus,a combination of paracetamol and caffeine. It is a targeted, fast and effective solution for headaches, which is also gentle on the stomach, according to various research studies. The launch of this new product marks the company’s foray into the OTC headache segment in India.
While announcing the launch, Anindya Chowdhury, Senior Director — Consumer Healthcare, Sanofi India said, “Today’s hectic and stressful lifestyles are impacting the quality of life and productivity of people.”
Data suggests that over 70 per cent of men and women experience an episode of headache every month, and 36 per cent suffer from it weekly, as per reports in GFK Market Research Findings 2012.
Chowdhury added, “We are pleased to introduce Combiflam Plus to our consumers which is a targeted solution for headaches. This combination is shown to have 89 per cent incremental analgesic effect (in terms of total pain relief) when compared with paracetamol monotherapy.”
Caffeine has been shown to have a synergistic and well documented adjuvant action when combined with analgesics (painkillers). Research in the Journal of the American Medical Association (JAMA) shows that adding caffeine to an analgesic for e.g. paracetamol, increases the potency of the analgesic by approximately 40 per cent.
In a first of its kind ‘Pack of 4s’ packaging in the headache category, Combiflam Plus is priced at Rs 9.50/-(MRP) and Combiflam Plus will be available in the states of Uttar Pradesh, Maharashtra, Tamil Nadu, West Bengal, Punjab and Haryana.
Combiflam Plus is a line extension of Combiflam, which has been a trusted brand in the Indian pharmaceutical market for over 25 years, and is present in ‘1 in every three households across India, according to Nielsen study on Combiflam Pricing.
EP News Bureau – Mumbai
- Advertisement -
